Life Science News

RSS

Defective astrocytes linked to alpha-synuclein accumulation in Parkinson's

Researchers have found that defects in brain glial cells called astrocytes are linked to the accumulation of alpha-synuclein in Parkinson's disease.

10 Jan 2019

Researchers identify promising therapeutic option to treat multiple sclerosis

Researchers at the Medical Center of Johannes Gutenberg University Mainz (JGU) identified an innovative and promising therapeutic option to treat multiple sclerosis.

10 Jan 2019

Unusual molecular regulatory mechanism discovered in unicellular parasites

Researchers of the University of Bern have discovered a new molecular regulatory mechanism in unicellular parasites which has never before been observed.

10 Jan 2019

New certified reference material for testing residual solvents in cannabis

This new certified reference material from Restek contains 20 commonly analyzed residual solvents in one convenient solution.

From Restek Corporation 10 Jan 2019

High-performing MS device reaches new level in characterizing protein impurities

In response to current regulatory guidance a Mass Spectrometry-based Host Cell Protein detection approach with faster, more accurate and wider-ranging detection is essential.

10 Jan 2019

Bacteria on the International Space Station are adapting to survive, not to harm

Mutant bacteria stranded in space by visiting astronauts have been adapting to survive in their new environment, according to a new study.

10 Jan 2019

New bacteria discovered in the blood of human patients

Two new species of bacteria have been found in the blood of patients in China.

10 Jan 2019

Study explains why some drugs work well in ameliorating side effects of chemotherapy

Researchers at the University of Zurich have determined the three-dimensional structure of the receptor that causes nausea and vomiting as a result of cancer chemotherapy.

10 Jan 2019

Using Multiplex Assays to Discover Biomarkers for Parkinson’s Disease

In this interview, Dr. Polinski and Dr. Atabakhsh discuss the importance of developing biomarkers for Parkinson’s and the partnership between MJFF and Abcam.

From Abcam 10 Jan 2019

Aptamer Group and AstraZeneca to develop new drug delivery vehicles

Aptamer Group today announced it has signed an agreement with AstraZeneca to explore the potential of using aptamer technology to target the kidney.

From AstraZeneca 10 Jan 2019

NYSCF announce partnership with Ngene to develop new disease treatments

The New York Stem Cell Foundation Research Institute today announced a partnership with Ngene Therapeutics Inc. to develop new disease treatments that leverage human stem cell research and novel gene editing techniques.

10 Jan 2019

Drug development options diversified with new manganese catalyst

A University of Illinois team of researchers led by chemistry professor M. Christina White has developed a new manganese-based catalyst that can change the structure of druglike molecules to make new drugs, advancing the pace and efficiency of drug development.

9 Jan 2019

University of Cincinnati professor awarded $1.6 million NIAID grant to study Hamburger E. coli

Alison Weiss, PhD, professor in the Department of Molecular Genetics, Biochemistry and Microbiology in UC College of Medicine, has been awarded a four-year grant of $1.6 million from the National Institute of Allergy and Infectious Diseases to study Shiga toxin producing Escherichia coli 0157:H7, also sometimes referred to as Hamburger E. coli.

9 Jan 2019

Stick insect study reveals importance of small limbs' passive muscle force for swift movements

Long, heavy limbs such as arms or legs differ fundamentally from short, light limbs such as fingers in their ability to execute fast movements. While the central nervous system has to actively control fast movements of large limbs, passive muscle force can suffice for the movement velocity and movement amplitude of small and light limbs.

9 Jan 2019

Metabolite from berries and pomegranates can mitigate inflammatory bowel disease

Millions of people suffer from inflammatory bowel disease worldwide, either in the form of ulcerative colitis or Crohn's disease, and few effective long-term treatments are available. Chronic intestinal inflammation is a hallmark of IBD.

9 Jan 2019

Olympus and USC announce new partnership to advance cancer research

The University of Southern California and Olympus have announced their first-ever co-development partnership with the goal of advancing multiscale research into cancer prevention, diagnosis, and treatment through precision medicine.

From Olympus Life Science Solutions 9 Jan 2019

Protein discovery could lead to mosquito "birth control"

Researchers have discovered a way of preventing mosquito eggs from hatching, paving the way for drugs that could serve as “birth control” within mosquito populations.

9 Jan 2019

New mechanism of gene regulation involved in tumor progression discovered

Genes contain all the information needed for the functioning of cells, tissues, and organs in our body. Gene expression, meaning when and how are the genes being read and executed, is thoroughly regulated like an assembly line with several things happening one after another.

9 Jan 2019

Microtube-embedded Chondroitinase ABC shows promise for treating spinal cord injuries

AMSBIO, a leading global supplier of Chondroitinase ABC enzyme, reports on the recent publication by Hu et al. of the therapeutic efficacy of microtube-embedded Chondroitinase ABC on a group of dogs with naturally occurring spinal injuries.

From AMS Biotechnology 9 Jan 2019

Expedeon signs license agreement for use of Lightning-Link technology

Expedeon AG, today announced it has signed a supply and license agreement with Cell Guidance Systems for use of Expedeon’s proprietary Lightning-Link Rapid Biotin..

From Expedeon 9 Jan 2019